Real-life comparison of afatinib and erlotinib in non-small cell lung cancer with rare EGFR exon 18 and exon 20 mutations: a Turkish Oncology Group (TOG) study
Titel:
Real-life comparison of afatinib and erlotinib in non-small cell lung cancer with rare EGFR exon 18 and exon 20 mutations: a Turkish Oncology Group (TOG) study
Auteur:
Gursoy, Pınar Tatli, Ali Murat Erdem, Dilek Goker, Erdem Celik, Emir Demirci, Nebi Serkan Sakin, Abdullah Atci, Muhammed Mustafa Bayram, Ertuğrul Telli, Tuğba Akın Bilgin, Burak Bilici, Ahmet Akangunduz, Baran Balli, Sevinç Demirkazik, Ahmet Selçukbiricik, Fatih Menekse, Serkan Cavdar, Eyyüp Ozturk, Akın Bekmez, Esma Türkmen Turhal, Serdal Kilickap, Sadettin Yildirim, Hasan Çağrı Oyan, Başak Aksoy, Asude Turkoz, Fatma Paksoy Kut, Engin Katgi, Nuran Sakalar, Teoman Akyol, Murat Ellez, Halil İbrahim Topcu, Atakan Erdoğan, Atike Pınar Pilanci, Kezban Nur Hedem, Engin Arak, Hacı Akdeniz, Nadiye Alan, Özkan Yapar, Burcu Nart, Deniz Yumuk, Perran Fulden